Alexion Pharmaceuticals
George Giannakopoulos, MSc. MBA, currently serves as the Director and Head of Business Operations for Haematology & Nephrology Global Medical Affairs at Alexion Pharmaceuticals, Inc., a position held since May 2020. Prior to this role, George contributed as an Associate Director in Health Economics & Outcomes Research at the same company and held key positions at Biogen and The Janssen Pharmaceutical Companies of Johnson & Johnson, focusing on corporate strategy, external alliances, and project management. An academic background includes a Master of Science in Science and Business Management from Utrecht University, an Executive MBA from the Rotterdam School of Management, Erasmus University, and various certifications in health economics and project management from other prestigious institutions. George's extensive experience spans across biomedical science, healthcare strategy, and operations in the pharmaceutical sector.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.